Third Wave Technologies Inc. today reported a third-quarter net loss of $5.2 million, or 12 cents per share, which was an improvement over a net loss of $7.4 million, or 18 cents per share, in the same period a year ago.
The Madison-based bio-technology's quarterly revenues increased to $6.6 million from $5.2 million a year earlier.
The company's net loss for the nine-month period ended Sept. 30 was $14.3 million, or 34 cents per share, compared with a net loss of $17.3 million, or ($0.42) a share for the same period of 2005.
"The third quarter was another quarter of outstanding accomplishment and solid progress for Third Wave," said Kevin Conroy, the company's president and chief executive. "It is the third consecutive quarter of both year-over- year and quarter-over-quarter growth in our core business, clinical molecular diagnostics. We also continued to lay the foundation for Third Wave's future growth, as we continued to make good progress in product development and in our HPV clinical trial, in particular."
Losses still piling up for Third Wave Technologies
Operand type clash: text is incompatible with int
advertisement
Sorry, the story you tried to comment on is not accepting comments.